RUCEVICMarijana Olink PSX, part of Thermo Fisher ScientificSweden

RUCEVICMarijana
• Ph.D. Scientist with 15 years of academic and industry experience in protein biochemistry, biomarkers, immunology, immunooncology and clinical analysis. • Expertise in protein biomarkers and immonopeptidome discovery and characterization using combined immuno-biochemical and LC-MS/MS approaches. Extensive training in related state-of-the-art techniques. • Experience managing research projects. Ability to learn quickly in new research areas. • Collaboration and leadership experience. Strong problem solving and technical skills, excellent communication and organization skills. Specialties: Biochemistry, multiplexing Proximity Extension Assay, LC-MS-proteomics and HLA-immunopeptidomics, proteins/peptides isolation and characterization, immunoprecipitation, electrophoresis, western blotting, ELISA, HPLC, Mass spectrometry (LC-ESI-MS/MS, MALDI-TOF/TOF, MALDI Immaging), MS data analysis, molecular biology, cellular biology, transfection, tissue culture of human primary cells and mammalian cell lines, cell isolation and separation (EasyStep), in vitro primary cell assays and T cell responses assays (Elispot), flow cytometry.

Wednesday, 18 June 2025

Time Session
14:30
15:15
RUCEVICGuyonnetMarijana Industry Moderator/ Chair Sweden
  • Olink Proteomics: Accelerating progress in cancer research and the path to therapeutics
    RUCEVICGuyonnetMarijana Industry Speaker Sweden
  • Deep plasma proteomics identifies and validates an eight-protein biomarker panel for ovarian cancer
    EnrothStefan Industry Speaker Sweden
  • Liquid biopsy: Plasma proteomics to identify novel biomarkers
    ItalianoAntoine Industry Speaker France
  • Questions and Answers
Auditorium 2